{
    "clinical_study": {
        "@rank": "104278", 
        "arm_group": [
            {
                "arm_group_label": "RFA", 
                "arm_group_type": "Active Comparator", 
                "description": "Mapping and radiofrequency ablation are performed by using standard methods."
            }, 
            {
                "arm_group_label": "RFA+BT injection", 
                "arm_group_type": "Active Comparator", 
                "description": "Mapping and radiofrequency ablation are performed by using standard methods.\nInjection of the botulinum toxin is performed in main anatomical zones of ganglionated plexuses of left atrium using Myostar catheter (Biosense Webster)."
            }
        ], 
        "brief_summary": {
            "textblock": "The investigators have conducted a prospective, double-blind, randomized study to assess the\n      comparative safety and efficacy of two different ablation strategies, RFA versus RFA plus\n      botulinum toxin injection, in patients with supra-ventricular tachyarrhythmias. Results were\n      assessed with the use of an implanted monitoring device (IMD)."
        }, 
        "brief_title": "Botulinum Toxin Injection for Preventing Secondary Atrial Fibrillation in Patient With Supra-ventricular Tachyarrythmias", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Supra-ventricular Tachyarrhythmias", 
        "condition_browse": {
            "mesh_term": [
                "Atrial Fibrillation", 
                "Tachycardia", 
                "Tachycardia, Ventricular"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  atrial flutter, AV nodal re-entry tachycardia, focal atrial tachycardia, WPW syndrome\n\n          -  secondary atrial fibrillation\n\n        Exclusion Criteria:\n\n          -  congestive heart failure\n\n          -  LV ejection fraction < 35%\n\n          -  left atrial diameter > 60 mm"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "70 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 6, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02008461", 
            "org_study_id": "BT_SVT"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "RFA", 
                    "RFA+BT injection"
                ], 
                "intervention_name": "radiofrequency ablation", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "RFA+BT injection", 
                "intervention_name": "botulinum toxin injection", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Botulinum Toxins"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "December 6, 2013", 
        "link": {
            "description": "State Research Institute of Circulation Pathology Official Site", 
            "url": "http://meshalkin.ru"
        }, 
        "location": [
            {
                "contact": {
                    "email": "jss7@columbia.edu", 
                    "last_name": "Jonathan S. Steinberg"
                }, 
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "11528"
                    }, 
                    "name": "The Valley Health System and Columbia University College of Physicians & Surgeons"
                }, 
                "investigator": {
                    "last_name": "Jonathan S. Steinberg, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "E.Pokushalov@gmail.com", 
                    "last_name": "Evgeny Pokushalov, MD, PhD", 
                    "phone": "+79139254858"
                }, 
                "facility": {
                    "address": {
                        "city": "Novosibirsk", 
                        "country": "Russian Federation", 
                        "zip": "630055"
                    }, 
                    "name": "State Research Institute of Circulation Pathology"
                }, 
                "investigator": {
                    "last_name": "Evgeny Pokushalov, MD, PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "United States", 
                "Russian Federation"
            ]
        }, 
        "number_of_arms": "2", 
        "overall_contact": {
            "email": "e.pokushalov@gmail.com", 
            "last_name": "Evgeny Pokushalov, MD, PhD", 
            "phone": "+79139254858"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Russia: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "number of episodes of atrial fibrillation", 
            "safety_issue": "No", 
            "time_frame": "1 year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02008461"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "serious adverse events", 
            "safety_issue": "Yes", 
            "time_frame": "1 year"
        }, 
        "source": "Meshalkin Research Institute of Pathology of Circulation", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Meshalkin Research Institute of Pathology of Circulation", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}